Horizon Technology Finance Corporation

Horizon Technology Finance Corporation, an affiliate of Monroe Capital, has provided a $15 million senior credit facility to Bioness Medical, Inc., with an initial $10 million funded at closing and up to $5 million available to support Bioness's continued growth. Bioness develops FDA-approved neurorehabilitation technologies for individuals recovering from stroke, spinal cord injury, and other neurological conditions, and is backed by Accelmed Partners. Horizon's Chief Investment Officer, Paul Seitz, highlighted the company's focus on providing flexible growth capital to innovative companies with proven business models, while Bioness's CEO, Todd Cushman, noted the facility offers additional capital and flexibility for expanding its product portfolio and serving patients globally.